Literature DB >> 1640921

Management of persons exposed to multidrug-resistant tuberculosis.

.   

Abstract

Recent outbreaks of multidrug-resistant tuberculosis (MDR-TB) have posed challenges for the management of exposed persons. This report offers suggestions for evaluating and managing persons (i.e., contacts) who have been exposed to patients with infectious MDR-TB (TB due to strains of Mycobacterium tuberculosis resistant to both isoniazid [INH] and rifampin [RIF]), provides background information on alternative preventive therapy regimens with drugs other than INH or RIF, and presents considerations relevant to making a decision to offer one of these alternative regimens.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1640921

Source DB:  PubMed          Journal:  MMWR Recomm Rep        ISSN： 1057-5987


  15 in total

Review 1.  Epidemiological and clinical aspects of mycobacterial infections.

Authors:  M Opravil
Journal:  Infection       Date:  1997 Jan-Feb       Impact factor: 3.553

2.  Resource utilization for multidrug-resistant tuberculosis household contact investigations (A5300/I2003).

Authors:  S Swindells; A Gupta; S Kim; M D Hughes; J Sanchez; V Mave; R Dawson; N Kumarasamy; K Comins; B Smith; R Rustomjee; L Naini; N S Shah; A Hesseling; G Churchyard
Journal:  Int J Tuberc Lung Dis       Date:  2018-09-01       Impact factor: 2.373

3.  Why do child contacts of multidrug-resistant tuberculosis not come to the assessment clinic?

Authors:  K Zimri; A C Hesseling; P Godfrey-Faussett; H S Schaaf; J A Seddon
Journal:  Public Health Action       Date:  2012-09-21

Review 4.  Treatment and prevention of multidrug-resistant tuberculosis.

Authors:  I Bastian; R Colebunders
Journal:  Drugs       Date:  1999-10       Impact factor: 9.546

5.  Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline.

Authors:  Payam Nahid; Sundari R Mase; Giovanni Battista Migliori; Giovanni Sotgiu; Graham H Bothamley; Jan L Brozek; Adithya Cattamanchi; J Peter Cegielski; Lisa Chen; Charles L Daley; Tracy L Dalton; Raquel Duarte; Federica Fregonese; C Robert Horsburgh; Faiz Ahmad Khan; Fayez Kheir; Zhiyi Lan; Alfred Lardizabal; Michael Lauzardo; Joan M Mangan; Suzanne M Marks; Lindsay McKenna; Dick Menzies; Carole D Mitnick; Diana M Nilsen; Farah Parvez; Charles A Peloquin; Ann Raftery; H Simon Schaaf; Neha S Shah; Jeffrey R Starke; John W Wilson; Jonathan M Wortham; Terence Chorba; Barbara Seaworth
Journal:  Am J Respir Crit Care Med       Date:  2019-11-15       Impact factor: 21.405

6.  DNA fingerprinting of Mycobacterium tuberculosis isolates from epidemiologically linked case pairs.

Authors:  Diane E Bennett; Ida M Onorato; Barbara A Ellis; Jack T Crawford; Barbara Schable; Robert Byers; J Steve Kammerer; Christopher R Braden
Journal:  Emerg Infect Dis       Date:  2002-11       Impact factor: 6.883

7.  Proposed management of childhood tuberculosis in low-incidence countries.

Authors:  Klaus Magdorf; Anne K Detjen
Journal:  Eur J Pediatr       Date:  2008-05-10       Impact factor: 3.183

Review 8.  Current and potential treatment of tuberculosis.

Authors:  S Houston; A Fanning
Journal:  Drugs       Date:  1994-11       Impact factor: 9.546

Review 9.  Systematic Review, Meta-analysis, and Cost-effectiveness of Treatment of Latent Tuberculosis to Reduce Progression to Multidrug-Resistant Tuberculosis.

Authors:  Suzanne M Marks; Sundari R Mase; Sapna Bamrah Morris
Journal:  Clin Infect Dis       Date:  2017-06-15       Impact factor: 9.079

10.  Saudi guidelines for testing and treatment of latent tuberculosis infection.

Authors:  Hamdan H Al Jahdali; Salim Baharoon; Abdullah A Abba; Ziad A Memish; Abdulrahman A Alrajhi; Ali AlBarrak; Qais A Haddad; Mohammad Al Hajjaj; Madhukar Pai; Dick Menzies
Journal:  Ann Saudi Med       Date:  2010 Jan-Feb       Impact factor: 1.526
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.